Respiratory Medicine CME
Volume 1, Issue 1 , Pages 10-14, 2008

Imaging of pleural masses: Which to choose?—Republished article

Division of Pulmonary and Critical Care, The Ohio State University Medical Center, 473 West 12th Avenue, Columbus, OH 43210, USA

Summary 

The differential diagnosis of pleural masses is limited. Asbestos-related disease and invasive bronchogenic carcinoma make up the majority of cases. The diagnostic yield of biopsies is low, and invasive procedures are often required to achieve diagnosis. A variety of imaging techniques are available to help differentiate between benign and malignant disease to help discern which patients to biopsy. While computed tomography has a relatively good sensitivity and specificity, magnetic resonance imaging (MRI) and positron emission tomography (PET) both appear to have higher accuracy. MRI has the added benefit of being an excellent aid in determining surgical resectability of tumors. MRI and PET are limited, however, by their cost and availability in certain regions.

Keywords: Non-small cell lung carcinoma, Pleural neoplasms, Magnetic resonance imaging

 

 This article was first published in Respiratory Medicine, Vol. 102, Issue 3, pp. 328–331 and is re-published for the benefit of Respiratory Medicine - CME readers. Readers are requested to cite the original source when citing this article.

PII: S1755-0017(08)00014-6

doi:10.1016/j.rmedc.2008.02.002

Respiratory Medicine CME
Volume 1, Issue 1 , Pages 10-14, 2008